Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO issues notice of allowance for Amarin patent covering AMR101
A notice of allowance is issued after the USPTO makes a determination that a patent can be granted from an application. The issued patent, which would cover a
A notice of allowance is issued after the USPTO makes a determination that a patent can be granted from an application. The issued patent, which would cover a
According to ThermoGenesis, the payment is due during the company’s first fiscal quarter of 2013. ThermoGenesis chief executive officer Matthew Plavan said the divestiture is an important milestone
Under the agreement, SSB will provide Bosch with pre-configured single-use filling transfer sets, consisting of bags, filters, tubing and connectors. Bosch will combine them with its aseptic filling
The pre-configured version of Oracle Health Sciences Empirica Topics uses BioPharm’s methodology to facilitate the formal prioritization and evaluation of signals identified within a company. BioPharm Systems safety
The two outlets are located at 9140 Guilbeau Road and 22202 Bulverde Road, San Antonio. The clinics will operate seven days a week including weekday evenings and no
The deal is intended for the production of hyperimmune colostrum for Immuron’s products, including its Travelan treatment for travellers’ diarrhoea. Immuron chief executive officer Joe Baini said, "As
XCAT-KS is a PCR / pyrosequencing based bloodless test which identifies KS and other male sex chromosome aneuploidies with 100% sensitivity and specificity. The company said, following receipt
Pharmacy technologists called on the council at the closing session of a four-day training program on advocacy, organised by the Business Sector Advocacy Challenge (BUSAC) Fund, reported GhanaWeb.
The sequence-based assays utilize the company’s 454 GS Junior and GS FLX systems and enable deep sequencing of PCR amplicons covering key exon regions of human TET2, CBL,
The single-blind, randomized trial is expected to enrol 72 obese patients, with a body mass index between 30 and 35kg/m². The primary objective of the placebo-controlled trial is